Source: EconoTimes

Press Release: ReNetx : ReNetX Bio Receives $7M Commitment from Wings for Life to Bring Spinal Cord Treatment to Trial

The Wings for Life foundation has made a significant commitment to ReNetX Bio, a New-Haven, Conn. based biotech startup that is advancing a cutting-edge therapy for chronic spinal cord injury to clinical trial.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Erika R. Smith's photo - CEO of ReNetx

CEO

Erika R. Smith

CEO Approval Rating

75/100

Read more